A replicable method for blood glucose control in critically Ill patients
Authors:
- Alan H. MorrisAMAlan H. Morris
- James Jr OrmeJOJames Jr Orme
- Jonathon D. TruwitJTJonathon D. Truwit
- Jay SteingrubJSJay Steingrub
- Colin GrissomCGColin Grissom
- Kang H. LeeKLKang H. Lee
- Guoliang L. LiGuoliang L. Li
- B Taylor ThompsonBTB Taylor Thompson
- Roy BrowerRBRoy Brower
- Mark TidswellMTMark Tidswell
- Gordon R. BernardGBGordon R. Bernard
- Dean SorensonDSDean Sorenson
- 1 June 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 36 (6) , 1787-1795
Abstract
Context: To ensure interpretability and replicability of clinical experiments, methods must be adequately explicit and should elicit the same decision from different clinicians who comply with the study protocol. Objective: The objective of this study was to determine whether clinician compliance with protocol recommendations exceeds 90%. Design: We developed an adequately explicit computerized protocol (eProtocol-insulin) for managing critically ill adult patient blood glucose. We monitored clinician compliance with eProtocol-insulin recommendations in four intensive care units in four hospitals and compared blood glucose distributions with those of a simple clinical guideline at one hospital and a paper-based protocol at another. All protocols and the guideline used intravenous insulin and 80 to 110 mg/dL (4.4–6.1 mmol/L) blood glucose targets. Setting: The setting for this study was four academic hospital intensive care units. Patients: This study included critically ill adults requiring intravenous insulin. Intervention: Intervention used in this study was a bedside computerized protocol for managing blood glucose. Main Outcome Measure: The main outcome measure was clinician compliance with eProtocol-insulin recommendations. Results: The number of patients was 31 to 458 and the number of blood glucose measurements was 2,226 to 19,925 among the four intensive care units. Clinician compliance with eProtocol-insulin recommendations was 91% to 98%. Blood glucose distributions were similar in the four hospitals (generalized linear model p = .18). Compared with the simple guideline, eProtocol-insulin glucose measurements within target increased from 21% to 39%, and mean blood glucose decreased from 142 to 115 mg/dL (generalized linear model p < .001). Compared with the paper-based protocol, eProtocol-insulin glucose measurements within target increased from 28% to 42%, and mean blood glucose decreased from 134 to 116 mg/dL (generalized linear model p = .001). Conclusions: The 91% to 98% clinician compliance indicates eProtocol-insulin is an exportable instrument that can establish a replicable experimental method for clinical trials of blood glucose management in critically ill adults. Control of blood glucose was better with eProtocol-insulin than with a simple clinical guideline or a paper-based protocol.Keywords
This publication has 27 references indexed in Scilit:
- Intensive Insulin Therapy in the Medical ICUNew England Journal of Medicine, 2006
- Complex interventions: how “out of control” can a randomised controlled trial be?BMJ, 2004
- Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*Critical Care Medicine, 2003
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001
- What Makes Clinical Research Ethical?JAMA, 2000
- Developing and Implementing Computerized Protocols for Standardization of Clinical DecisionsAnnals of Internal Medicine, 2000
- Assessing the Generalizability of Prognostic InformationAnnals of Internal Medicine, 1999
- Users' Guides to the Medical LiteratureJAMA, 1993
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Small Area Variations in Health Care DeliveryScience, 1973